Back to Search
Start Over
Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases
- Source :
- Journal of the National Cancer Institute. 95(6)
- Publication Year :
- 2003
-
Abstract
- BACKGROUND Expression of platelet-derived growth factor (PDGF) and activation (by autophosphorylation) of its receptor (PDGF-R), a tyrosine kinase, are associated with the growth of metastatic prostate tumor cells in the bone parenchyma. The tyrosine kinase inhibitor STI571 blocks the PDGF signaling pathway by inhibiting PDGF-R autophosphorylation. We examined the effects of STI571, given alone or with paclitaxel (Taxol), on tumor growth in a mouse model of prostate cancer metastasis. METHODS Human prostate cancer PC-3MM2 cells were injected into the tibias of male nude mice. Three days later the mice (20 per group) were randomly assigned to 5 weeks of treatment with oral and injected water (control), daily oral STI571, weekly injected paclitaxel, or STI571 plus paclitaxel. Lesions in bone and the surrounding muscles were then harvested and analyzed by histology, western blotting (for PDGF-R phosphorylation), immunohistochemistry (for expression of proangiogenic molecules), and double immunofluorescence (to identify endothelial cells and apoptotic tumor cells). Growth of bone lesions was monitored by digital radiography. Bone lesions from control mice were used to establish short-term cell cultures for analysis of PDGF-R phosphorylation. All statistical tests were two-sided. RESULTS PC-3MM2 cells cultured from bone lesions and treated in vitro with STI571 had less phosphorylated PDGF-R than untreated cells. In control mice, bone lesions expressed high levels of PDGF and activated (i.e., phosphorylated) PDGF-R, whereas lesions in the adjacent musculature did not. Activated PDGF-R was present on the surface of endothelial cells within the bone lesions but not in endothelial cells of uninjected bone. Mice treated with STI571 or STI571 plus paclitaxel had a lower tumor incidence, smaller tumors, and less bone lysis and lymph node metastasis than mice treated with water or paclitaxel alone (P
- Subjects :
- Male
Cancer Research
Pathology
Platelet-derived growth factor
medicine.medical_treatment
Administration, Oral
Fluorescent Antibody Technique
Apoptosis
Piperazines
Metastasis
Prostate cancer
chemistry.chemical_compound
Mice
PDGF Signaling Pathway
Antineoplastic Combined Chemotherapy Protocols
Tumor Cells, Cultured
Receptors, Platelet-Derived Growth Factor
Enzyme Inhibitors
Phosphorylation
Platelet-Derived Growth Factor
biology
Bone metastasis
Protein-Tyrosine Kinases
Immunohistochemistry
Gene Expression Regulation, Neoplastic
Radiographic Image Enhancement
Oncology
Benzamides
Imatinib Mesylate
Platelet-derived growth factor receptor
Cell Division
Signal Transduction
medicine.medical_specialty
Paclitaxel
Blotting, Western
Mice, Nude
Antineoplastic Agents
Bone Neoplasms
medicine
In Situ Nick-End Labeling
Animals
Humans
business.industry
Growth factor
Microcirculation
Prostatic Neoplasms
Neoplasms, Experimental
medicine.disease
Antineoplastic Agents, Phytogenic
Disease Models, Animal
Imatinib mesylate
Pyrimidines
chemistry
biology.protein
business
Subjects
Details
- ISSN :
- 00278874
- Volume :
- 95
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Journal of the National Cancer Institute
- Accession number :
- edsair.doi.dedup.....61bc866225ab6e4910b03d4fe49092e5